BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
106 hedge funds and large institutions have $828M invested in BELLUS Health Inc. in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 23 closing their positions.
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
16% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 32
11% less capital invested
Capital invested by funds: $933M → $828M (-$104M)
12% less funds holding
Funds holding: 121 → 106 (-15)
57% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 23
77% less call options, than puts
Call options by funds: $158K | Put options by funds: $682K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
+$25.5M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.1M |
| 3 |
Millennium Management
New York
|
+$11.6M |
| 4 |
CC
Commodore Capital
New York
|
+$9.9M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$8.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$30.5M |
| 2 |
AG
Artal Group
Luxembourg
|
-$30.4M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$5.49M |
| 4 |
Goldman Sachs
New York
|
-$5.16M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.11M |
BLU Hedge Fund Activity: Q1 2023 in Review
106 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q1 2023, worth a combined $828M — down 11% from $933M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of BLU and 10 opened new positions — a net loss of 13 holders — while 32 trimmed existing stakes and 37 added.
The largest buyer was Laurion Capital Management, adding an estimated $25.5M. The largest seller was Perceptive Advisors, cutting an estimated $30.5M.
- 106 institutional investors held BELLUS Health Inc. (BLU) as of Q1 2023, down from 121 in Q4 2022.
- Funds reported $828M of BELLUS Health Inc. stock for Q1 2023, down 11% quarter-over-quarter.
- 10 funds opened new BELLUS Health Inc. positions in Q1 2023 and 23 closed out, a net change of -13 holders.
- The largest BELLUS Health Inc. buyer in Q1 2023 was Laurion Capital Management, an estimated $25.5M added.
- The largest BELLUS Health Inc. seller in Q1 2023 was Perceptive Advisors, an estimated $30.5M sold.
Based on aggregated 13F filings for Q1 2023.